Study of EXPAREL in Patients Undergoing Breast Augmentation
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This is a Phase 4, prospective, open-label, non-randomized, sequential study with two
treatment groups differing only in the technique used for EXPAREL administration
(instillation or infiltration).